Establishment and characterization of a new human myxoid liposarcoma cell line (DL-221) with the FUS-DDIT3 translocation

A phase II study of SB939, a novel pan-histone deacetylase inhibitor, in patients with translocation-associated recurrent/metastatic sarcomas—NCIC-CTG IND 200†

(2015) Q. S.-C. Chu et al.   ANNALS OF ONCOLOGY

HDAC Inhibition for the Treatment of Epithelioid Sarcoma: Novel Cross Talk Between Epigenetic Components

(2015) G. Lopez et al.   MOLECULAR CANCER RESEARCH

A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1-Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response

(2014) P. F. Robbins et al.   CLINICAL CANCER RESEARCH

TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entities

(2014) Christian Koelsche et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

NY-ESO-1 (CTAG1B) expression in mesenchymal tumors

(2014) Makoto Endo et al.   MODERN PATHOLOGY

Normal and Functional TP53 in Genetically Stable Myxoid/Round Cell Liposarcoma

(2014) Anders Ståhlberg et al.   PLoS One

Predicting the functional consequences of cancer-associated amino acid substitutions

(2013) Hashem A. Shihab et al.   BIOINFORMATICS

A phase II trial of panobinostat in patients with advanced pretreated soft tissue sarcoma. A study from the French Sarcoma Group

(2013) P A Cassier et al.   BRITISH JOURNAL OF CANCER

Localized and metastatic myxoid/round cell liposarcoma

(2013) Aviad Hoffman et al.   CANCER

Diverse Mechanisms of Somatic Structural Variations in Human Cancer Genomes

(2013) Lixing Yang et al.   CELL

Myxoid liposarcoma and the mammalian target of rapamycin pathway

(2013) Roberta Sanfilippo et al.   CURRENT OPINION IN ONCOLOGY

Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples

(2013) Kristian Cibulskis et al.   NATURE BIOTECHNOLOGY

Frequency of TERT promoter mutations in human cancers

(2013) João Vinagre et al.   Nature Communications

NY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma

(2012) Seth M. Pollack et al.   CANCER

The cancer-testis antigen NY-ESO-1 is highly expressed in myxoid and round cell subset of liposarcomas

(2012) Jessica A Hemminger et al.   MODERN PATHOLOGY

Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model

(2012) Elizabeth G Demicco et al.   MODERN PATHOLOGY

Myxoid Liposarcoma-Associated EWSR1-DDIT3 Selectively Represses Osteoblastic and Chondrocytic Transcription in Multipotent Mesenchymal Cells

(2012) Kayo Suzuki et al.   PLoS One

Myxoid\Round Cell Liposarcoma (MRCLS) Revisited: An Analysis of 418 Primarily Managed Cases

(2011) Louis-Charles Moreau et al.   ANNALS OF SURGICAL ONCOLOGY

Functional Mapping of Receptor Tyrosine Kinases in Myxoid Liposarcoma

(2010) T. Negri et al.   CLINICAL CANCER RESEARCH

Clinicopathologic Prognostic Factors of Pure Myxoid Liposarcoma of the Extremities and Trunk Wall

(2010) Yoshihiro Nishida et al.   CLINICAL ORTHOPAEDICS AND RELATED RESEARCH

Multifocal Myxoid Liposarcoma—Metastasis or Second Primary Tumor?

(2010) Ronald de Vreeze et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Detection of myxoid liposarcoma-associated FUS–DDIT3 rearrangement variants including a newly identified breakpoint using an optimized RT-PCR assay

(2010) Martin P Powers et al.   MODERN PATHOLOGY

Kinome profiling of myxoid liposarcoma reveals NF-kappaB-pathway kinase activity and Casein Kinase II inhibition as a potential treatment option

(2010) Stefan M Willems et al.   Molecular Cancer

Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy

(2010) Jordi Barretina et al.   NATURE GENETICS

Vimentin Is a Novel Anti-Cancer Therapeutic Target; Insights from In Vitro and In Vivo Mice Xenograft Studies

(2010) Guy Lahat et al.   PLoS One

VarScan: variant detection in massively parallel sequencing of individual and pooled samples

(2009) Daniel C. Koboldt et al.   BIOINFORMATICS

Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads

(2009) K. Ye et al.   BIOINFORMATICS

Fast and accurate short read alignment with Burrows-Wheeler transform

(2009) H. Li et al.   BIOINFORMATICS

Validation of immature adipogenic status and identification of prognostic biomarkers in myxoid liposarcoma using tissue microarrays

(2009) Hongwei Cheng et al.   HUMAN PATHOLOGY

BreakDancer: an algorithm for high-resolution mapping of genomic structural variation

(2009) Ken Chen et al.   NATURE METHODS

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

(2009) Da Wei Huang et al.   Nature Protocols

The TET Family of Proteins: Functions and Roles in Disease

(2009) A. Y. Tan et al.   Journal of Molecular Cell Biology

Midkine Enhances Soft-Tissue Sarcoma Growth: A Possible Novel Therapeutic Target

(2008) Z. Jin et al.   CLINICAL CANCER RESEARCH

Histone deacetylase inhibitors induce growth arrest, apoptosis, and differentiation in clear cell sarcoma models

(2008) Shuzhen Liu et al.   MOLECULAR CANCER THERAPEUTICS

Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists

(2008) Da Wei Huang et al.   NUCLEIC ACIDS RESEARCH

The myxoid liposarcoma FUS-DDIT3 fusion oncoprotein deregulates NF-κB target genes by interaction with NFKBIZ

(2008) M Göransson et al.   ONCOGENE

FUS-DDIT3 Prevents the Development of Adipocytic Precursors in Liposarcoma by Repressing PPARγ and C/EBPα and Activating eIF4E

(2008) Pedro A. Pérez-Mancera et al.   PLoS One